Human skin mast cells express complement factors C3 and C5

Journal of Immunology

Volumn 191, Issue 4, 2013, Pages 1827-1834

  Fukuoka, Yoshihiro ^a   Hite, Michelle R ^a   Dellinger, Anthony L ^a   Schwartz, Lawrence B ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TRYPTASE; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5; CYTOKINE; FC RECEPTOR; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; JANUS KINASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUTRALIZING ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION (PARAMETERS); CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG; MAST CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETORY GRANULE; SKIN; WESTERN BLOTTING;

CELLS, CULTURED; COMPLEMENT C3; COMPLEMENT C3A; COMPLEMENT C3B; COMPLEMENT C5; CULTURE MEDIA, CONDITIONED; DRUG SYNERGISM; HUMANS; INTERLEUKINS; LUNG; MAST CELLS; NF-KAPPA B; PROTEIN KINASE INHIBITORS; RNA, MESSENGER; SIGNAL TRANSDUCTION; SKIN; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS; TRYPTASES; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS;

EID: 84881407415     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202889     Document Type: Article

References (101)

1. Malaviya, R., T. Ikeda, E. Ross, and S. N. Abraham. 1996. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 381: 77-80.
2. Dawicki, W., and J. S. Marshall. 2007. New and emerging roles for mast cells in host defence. Curr. Opin. Immunol. 19: 31-38.
3. Moon, T. C., C. D. St Laurent, K. E. Morris, C. Marcet, T. Yoshimura, Y. Sekar, and A. D. Befus. 2010. Advances in mast cell biology: new understanding of heterogeneity and function. Mucosal Immunol. 3: 111-128.
4. Tsai, M., M. Grimbaldeston, and S. J. Galli. 2011. Mast cells and immunoregulation/immunomodulation. Adv. Exp. Med. Biol. 716: 186-211.
5. Rodewald, H. R., and T. B. Feyerabend. 2012. Widespread immunological functions of mast cells: fact or fiction? Immunity 37: 13-24.
6. Galli, S. J., and M. Tsai. 2010. Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity. Eur. J. Immunol. 40: 1843-1851.
7. Morgan, B. P., K. J. Marchbank, M. P. Longhi, C. L. Harris, and A. M. Gallimore. 2005. Complement: central to innate immunity and bridging to adaptive responses. Immunol. Lett. 97: 171-179.
8. Hawlisch, H., and J. Köhl. 2006. Complement and Toll-like receptors: key regulators of adaptive immune responses. Mol. Immunol. 43: 13-21.
9. Daha, M. R. 2010. Role of complement in innate immunity and infections. Crit. Rev. Immunol. 30: 47-52.
10. Kwan, W. H., D. Hashimoto, E. Paz-Artal, K. Ostrow, M. Greter, H. Raedler, M. E. Medof, M. Merad, and P. S. Heeger. 2012. Antigen-presenting cell-derived complement modulates graft-versus-host disease. J. Clin. Invest. 122: 2234-2238.
11. Carroll, M. C., and D. E. Isenman. 2012. Regulation of humoral immunity by complement. Immunity 37: 199-207.
12. Johnson, A. R., T. E. Hugli, and H. J. Müller-Eberhard. 1975. Release of histamine from rat mast cells by the complement peptides C3a and C5a. Immunology 28: 1067-1080.
13. Jürgensen, H., H. Behrendt, B. Damerau, and W. Schmutzler. 1986. The effects of the anaphylatoxins C3a and C5a on isolated mast cells from rat and man. Agents Actions 18: 153-154.
14. el-Lati, S. G., C. A. Dahinden, and M. K. Church. 1994. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells. J. Invest. Dermatol. 102: 803-806.
15. Füreder, W., H. Agis, M. Willheim, H. C. Bankl, U. Maier, K. Kishi, M. R. Müller, K. Czerwenka, T. Radaszkiewicz, J. H. Butterfield, et al. 1995. Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells. J. Immunol. 155: 3152-3160.
16. Zwirner, J., O. Götze, A. Sieber, A. Kapp, G. Begemann, T. Zuberbier, and T. Werfel. 1998. The human mast cell line HMC-1 binds and responds to C3a but not C3a(desArg). Scand. J. Immunol. 47: 19-24.
17. Venkatesha, R. T., E. Berla Thangam, A. K. Zaidi, and H. Ali. 2005. Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase. Mol. Immunol. 42: 581-587.
18. Irani, A. A., N. M. Schechter, S. S. Craig, G. DeBlois, and L. B. Schwartz. 1986. Two types of human mast cells that have distinct neutral protease compositions. Proc. Natl. Acad. Sci. USA 83: 4464-4468.
19. Oskeritzian, C. A., W. Zhao, H. K. Min, H. Z. Xia, A. Pozez, J. Kiev, and L. B. Schwartz. 2005. Surface CD88 functionally distinguishes the MCTC from theMCT type of human lung mast cell. J. Allergy Clin. Immunol. 115: 1162-1168.
20. Schwartz, L. B. 2006. Analysis of MC(T) and MC(TC) mast cells in tissue. Methods Mol. Biol. 315: 53-62.
21. Valent, P., E. Spanblöchl, W. R. Sperr, C. Sillaber, K. M. Zsebo, H. Agis, H. Strobl, K. Geissler, P. Bettelheim, and K. Lechner. 1992. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in longterm culture. Blood 80: 2237-2245.
22. + pluripotent progenitor cells. J. Immunol. 148: 772-777.
23. Irani, A. M., G. Nilsson, U. Miettinen, S. S. Craig, L. K. Ashman, T. Ishizaka, K. M. Zsebo, and L. B. Schwartz. 1992. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 80: 3009-3021.
24. Mitsui, H., T. Furitsu, A. M. Dvorak, A. M. Irani, L. B. Schwartz, N. Inagaki, M. Takei, K. Ishizaka, K. M. Zsebo, S. Gillis, and T. Ishizaka. 1993. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc. Natl. Acad. Sci. USA 90: 735-739.
25. Kambe, N., M. Kambe, J. P. Kochan, and L. B. Schwartz. 2001. Human skinderived mast cells can proliferate while retaining their characteristic functional and protease phenotypes. Blood 97: 2045-2052.
26. Fukuoka, Y., H. Z. Xia, L. B. Sanchez-Muñoz, A. L. Dellinger, L. Escribano, and L. B. Schwartz. 2008. Generation of anaphylatoxins by human betatryptase from C3, C4, and C5. J. Immunol. 180: 6307-6316.
27. Ali, H. 2010. Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a. Immunol. Lett. 128: 36-45.
28. Schafer, B., A. M. Piliponsky, T. Oka, C. H. Song, N. P. Gerard, C. Gerard, M. Tsai, J. Kalesnikoff, and S. J. Galli. 2012. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice. J. Allergy Clin. Immunol. 131: 541-548.e1-9.
29. Colten, H. R., R. C. Strunk, D. H. Perlmutter, and F. S. Cole. 1986. Regulation of complement protein biosynthesis in mononuclear phagocytes. Ciba Found. Symp. 118: 141-154.
30. Brooimans, R. A., A. P. Stegmann, W. T. van Dorp, A. A. van der Ark, F. J. van der Woude, L. A. van Es, and M. R. Daha. 1991. Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. J. Clin. Invest. 88: 379-384.
31. Rothman, B., A. Despins, S. Webb, D. Taylor, N. Sundarraj, J. O'Rourke, and D. Kreutzer. 1991. Cytokine regulation of C3 and C5 production by human corneal fibroblasts. Exp. Eye Res. 53: 353-361.
32. Ueda, Y., K. Nagasawa, H. Tsukamoto, T. Horiuchi, H. Nishizaka, K. Ikeda, and Y. Niho. 1996. Production of the third and fourth component of complement (C3, C4) by smooth muscle cells. Immunology 89: 183-188.
33. Laufer, J., R. Oren, N. Farzam, I. Goldberg, and J. Passwell. 1997. Differential cytokine regulation of complement proteins in human glomerular epithelial cells. Nephron 76: 276-283.
34. Sheerin, N. S., W. Zhou, S. Adler, and S. H. Sacks. 1997. TNF-alpha regulation of C3 gene expression and protein biosynthesis in rat glomerular endothelial cells. Kidney Int. 51: 703-710.
35. Ueki, A., T. Sai, H. Oka, M. Tabata, K. Hosokawa, and Y. Mochizuki. 1987. Biosynthesis and secretion of the third component of complement by human endothelial cells in vitro. Immunology 61: 11-14.
36. Thomas, A., P. Gasque, D. Vaudry, B. Gonzalez, and M. Fontaine. 2000. Expression of a complete and functional complement system by human neuronal cells in vitro. Int. Immunol. 12: 1015-1023.
37. Pasch, M. C., N. H. Van Den Bosch, M. R. Daha, J. D. Bos, and S. S. Asghar. 2000. Synthesis of complement components C3 and factor B in human keratinocytes is differentially regulated by cytokines. J. Invest. Dermatol. 114: 78-82.
38. Katz, Y., D. Stav, J. Barr, and J. H. Passwell. 1995. IL-13 results in differential regulation of the complement proteins C3 and factor B in tumour necrosis factor (TNF)-stimulated fibroblasts. Clin. Exp. Immunol. 101: 150-156.
39. Katz, Y., O. Nadiv, M. J. Rapoport, and M. Loos. 2000. IL-17 regulates gene expression and protein synthesis of the complement system, C3 and factor B, in skin fibroblasts. Clin. Exp. Immunol. 120: 22-29.
40. Purwar, R., M. Wittmann, J. Zwirner, M. Oppermann, M. Kracht, O. Dittrich-Breiholz, R. Gutzmer, and T. Werfel. 2006. Induction of C3 and CCL2 by C3a in keratinocytes: a novel autocrine amplification loop of inflammatory skin reactions. J. Immunol. 177: 4444-4450.
41. Peng, Q., K. Li, H. Patel, S. H. Sacks, and W. Zhou. 2006. Dendritic cell synthesis of C3 is required for full T cell activation and development of a Th1 phenotype. J. Immunol. 176: 3330-3341.
42. Pratt, J. R., S. A. Basheer, and S. H. Sacks. 2002. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat. Med. 8: 582-587.
43. Zhou, W., H. Patel, K. Li, Q. Peng, M. B. Villiers, and S. H. Sacks. 2006. Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells. Blood 107: 2461-2469.
44. Kumar, V., S. R. Ali, S. Konrad, J. Zwirner, J. S. Verbeek, R. E. Schmidt, and J. E. Gessner. 2006. Cell-derived anaphylatoxins as key mediators of antibodydependent type II autoimmunity in mice. J. Clin. Invest. 116: 512-520.
45. Lalli, P. N., M. G. Strainic, F. Lin, M. E. Medof, and P. S. Heeger. 2007. Decay accelerating factor can control T cell differentiation into IFN-gammaproducing effector cells via regulating local C5a-induced IL-12 production. J. Immunol. 179: 5793-5802.
46. Strainic, M. G., J. Liu, D. Huang, F. An, P. N. Lalli, N. Muqim, V. S. Shapiro, G. R. Dubyak, P. S. Heeger, and M. E. Medof. 2008. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity 28: 425-435.
47. Peng, Q., K. Li, K. Anderson, C. A. Farrar, B. Lu, R. A. Smith, S. H. Sacks, and W. Zhou. 2008. Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction. Blood 111: 2452-2461.
48. Li, K., K. J. Anderson, Q. Peng, A. Noble, B. Lu, A. P. Kelly, N. Wang, S. H. Sacks, and W. Zhou. 2008. Cyclic AMP plays a critical role in C3areceptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation. Blood 112: 5084-5094.
49. Schepp-Berglind, J., C. Atkinson, M. Elvington, F. Qiao, P. Mannon, and S. Tomlinson. 2012. Complement-dependent injury and protection in a murine model of acute dextran sulfate sodium-induced colitis. J. Immunol. 188: 6309-6318.
50. Ramaglia, V., T. R. Hughes, R. M. Donev, M. M. Ruseva, X. Wu, I. Huitinga, F. Baas, J. W. Neal, and B. P. Morgan. 2012. C3-dependent mechanism of microglial priming relevant to multiple sclerosis. Proc. Natl. Acad. Sci. USA 109: 965-970.
51. Prodeus, A. P., X. N. Zhou, M. Maurer, S. J. Galli, and M. C. Carroll. 1997. Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature 390: 172-175.
52. Schäfer, B., A. M. Piliponsky, T. Oka, C. H. Song, N. P. Gerard, C. Gerard, M. Tsai, J. Kalesnikoff, and S. J. Galli. 2013. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice. J. Allergy Clin. Immunol. 131: 541-548, e1-e9.
53. Fukuoka, Y., and L. B. Schwartz. 2006. The B12 anti-tryptase monoclonal antibody disrupts the tetrameric structure of heparin-stabilized beta-tryptase to form monomers that are inactive at neutral pH and active at acidic pH. J. Immunol. 176: 3165-3172.
54. Riske, F., J. Hakimi, M. Mallamaci, M. Griffin, B. Pilson, N. Tobkes, P. Lin, W. Danho, J. Kochan, and R. Chizzonite. 1991. High affinity human IgE receptor (Fc ε RI). Analysis of functional domains of the α-subunit with monoclonal antibodies. J. Biol. Chem. 266: 11245-11251.
55. Xia, H.-Z., C. L. Kepley, K. Sakai, J. Chelliah, A.-M. A. Irani, and L. B. Schwartz. 1995. Quantitation of tryptase, chymase, Fc ε RI α, and Fc ε RI gamma mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction. J. Immunol. 154: 5472-5480.
56. Craig, S. S., N. M. Schechter, and L. B. Schwartz. 1988. Ultrastructural analysis of human T and TC mast cells identified by immunoelectron microscopy. Lab. Invest. 58: 682-691.
57. Craig, S. S., N. M. Schechter, and L. B. Schwartz. 1989. Ultrastructural analysis of maturing human T and TC mast cells in situ. Lab. Invest. 60: 147-157.
58. Schwartz, L. B., R. A. Lewis, D. Seldin, and K. F. Austen. 1981. Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells. J. Immunol. 126: 1290-1294.
59. Schwartz, L. B., K. F. Austen, and S. I. Wasserman. 1979. Immunologic release of beta-hexosaminidase and beta-glucuronidase from purified rat serosal mast cells. J. Immunol. 123: 1445-1450.
60. Perl, M., S. Denk, M. Kalbitz, and M. Huber-Lang. 2012. Granzyme B: a new crossroad of complement and apoptosis. Adv. Exp. Med. Biol. 946: 135-146.
61. Huber-Lang, M., E. M. Younkin, J. V. Sarma, N. Riedemann, S. R. McGuire, K. T. Lu, R. Kunkel, J. G. Younger, F. S. Zetoune, and P. A. Ward. 2002. Generation of C5a by phagocytic cells. Am. J. Pathol. 161: 1849-1859.
62. Peake, P. W., S. O'Grady, B. A. Pussell, and J. A. Charlesworth. 1999. C3a is made by proximal tubular HK-2 cells and activates them via the C3a receptor. Kidney Int. 56: 1729-1736.
63. Christian-Ritter, K. K., L. D. Hill, E. B. Hoie, and T. L. Zach. 1994. Effect of interleukin-4 on the synthesis of the third component of complement by pulmonary epithelial cells. Am. J. Pathol. 144: 171-176.
64. Stapp, J. M., V. Sjoelund, H. A. Lassiter, R. C. Feldhoff, and P. W. Feldhoff. 2005. Recombinant rat IL-1beta and IL-6 synergistically enhance C3 mRNA levels and complement component C3 secretion by H-35 rat hepatoma cells. Cytokine 30: 78-85.
65. Coulpier, M., S. Andreev, C. Lemercier, H. Dauchel, O. Lees, M. Fontaine, and J. Ripoche. 1995. Activation of the endothelium by IL-1 alpha and glucocorticoids results in major increase of complement C3 and factor B production and generation of C3a. Clin. Exp. Immunol. 101: 142-149.
66. Varley, A. W., M. G. Coulthard, R. S. Meidell, R. D. Gerard, and R. S. Munford. 1995. Inflammation-induced recombinant protein expression in vivo using promoters from acute-phase protein genes. Proc. Natl. Acad. Sci. USA 92: 5346-5350.
67. Ramadori, G., and B. Christ. 1999. Cytokines and the hepatic acute-phase response. Semin. Liver Dis. 19: 141-155.
68. Shen, X., Z. Tian, M. J. Holtzman, and B. Gao. 2000. Cross-talk between interleukin 1beta (IL-1beta) and IL-6 signalling pathways: IL-1beta selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism. Biochem. J. 352: 913-919.
69. Katz, Y., and R. C. Strunk. 1989. IL-1 and tumor necrosis factor. Similarities and differences in stimulation of expression of alternative pathway of complement and IFN-beta 2/IL-6 genes in human fibroblasts. J. Immunol. 142: 3862-3867.
70. Katz, Y., M. Revel, and R. C. Strunk. 1989. Interleukin 6 stimulates synthesis of complement proteins factor B and C3 in human skin fibroblasts. Eur. J. Immunol. 19: 983-988.
71. Wilson, D. R., T. S. Juan, M. D. Wilde, G. H. Fey, and G. J. Darlington. 1990. A 58-base-pair region of the human C3 gene confers synergistic inducibility by interleukin-1 and interleukin-6. Mol. Cell. Biol. 10: 6181-6191.
72. Kawamura, N., L. Singer, R. A. Wetsel, and H. R. Colten. 1992. Cis- and transacting elements required for constitutive and cytokine-regulated expression of the mouse complement C3 gene. Biochem. J. 283: 705-712.
73. Kaur, D., F. Hollins, L. Woodman, W. Yang, P. Monk, R. May, P. Bradding, and C. E. Brightling. 2006. Mast cells express IL-13R alpha 1: IL-13 promotes human lung mast cell proliferation and Fc epsilon RI expression. Allergy 61: 1047-1053.
74. Toru, H., C. Ra, S. Nonoyama, K. Suzuki, J. Yata, and T. Nakahata. 1996. Induction of the high-affinity IgE receptor (Fc ε RI) on human mast cells by IL-4. Int. Immunol. 8: 1367-1373.
75. Bischoff, S. C., G. Sellge, A. Lorentz, W. Sebald, R. Raab, and M. P. Manns. 1999. IL-4 enhances proliferation and mediator release in mature human mast cells. Proc. Natl. Acad. Sci. USA 96: 8080-8085.
76. Lorentz, A., and S. C. Bischoff. 2001. Regulation of human intestinal mast cells by stem cell factor and IL-4. Immunol. Rev. 179: 57-60.
77. Roy, B., A. Bhattacharjee, B. Xu, D. Ford, A. L. Maizel, and M. K. Cathcart. 2002. IL-13 signal transduction in human monocytes: phosphorylation of receptor components, association with Jaks, and phosphorylation/activation of Stats. J. Leukoc. Biol. 72: 580-589.
78. Kelly-Welch, A. E., E. M. Hanson, M. R. Boothby, and A. D. Keegan. 2003. Interleukin-4 and interleukin-13 signaling connections maps. Science 300: 1527-1528.
79. Hershey, G. K. 2003. IL-13 receptors and signaling pathways: an evolving web. J. Allergy Clin. Immunol. 111: 677-690, quiz 691.
80. Kasaian, M. T., and D. K. Miller. 2008. IL-13 as a therapeutic target for respiratory disease. Biochem. Pharmacol. 76: 147-155.
81. Vik, D. P., P. Amiguet, G. J. Moffat, M. Fey, F. Amiguet-Barras, R. A. Wetsel, and B. F. Tack. 1991. Structural features of the human C3 gene: intron/exon organization, transcriptional start site, and promoter region sequence. Biochemistry 30: 1080-1085.
82. Ehret, G. B., P. Reichenbach, U. Schindler, C. M. Horvath, S. Fritz, M. Nabholz, and P. Bucher. 2001. DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites. J. Biol. Chem. 276: 6675-6688.
83. Guo, D., J. D. Dunbar, C. H. Yang, L. M. Pfeffer, and D. B. Donner. 1998. Induction of Jak/STAT signaling by activation of the type 1 TNF receptor. J. Immunol. 160: 2742-2750.
84. Miscia, S., M. Marchisio, A. Grilli, V. Di Valerio, L. Centurione, G. Sabatino, F. Garaci, G. Zauli, E. Bonvini, and A. Di Baldassarre. 2002. Tumor necrosis factor alpha (TNF-alpha) activates Jak1/Stat3-Stat5B signaling through TNFR- 1 in human B cells. Cell Growth Differ. 13: 13-18.
85. Chen, G., and D. V. Goeddel. 2002. TNF-R1 signaling: a beautiful pathway. Science 296: 1634-1635.
86. Wajant, H., K. Pfizenmaier, and P. Scheurich. 2003. Tumor necrosis factor signaling. Cell Death Differ. 10: 45-65.
87. Lee, P. J., X. Zhang, P. Shan, B. Ma, C. G. Lee, R. J. Homer, Z. Zhu, M. Rincon, B. T. Mossman, and J. A. Elias. 2006. ERK1/2 mitogen-activated protein kinase selectively mediates IL-13-induced lung inflammation and remodeling in vivo. J. Clin. Invest. 116: 163-173.
88. Humbles, A. A., B. Lu, C. A. Nilsson, C. Lilly, E. Israel, Y. Fujiwara, N. P. Gerard, and C. Gerard. 2000. A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature 406: 998-1001.
89. Bautsch, W., H. G. Hoymann, Q. Zhang, I. Meier-Wiedenbach, U. Raschke, R. S. Ames, B. Sohns, N. Flemme, A. Meyerzu Vilsendorf, M. Grove, et al. 2000. Cutting edge: guinea pigs with a natural C3a-receptor defect exhibit decreased bronchoconstriction in allergic airway disease: evidence for an involvement of the C3a anaphylatoxin in the pathogenesis of asthma. J. Immunol. 165: 5401-5405.
90. Krug, N., T. Tschernig, V. J. Erpenbeck, J. M. Hohlfeld, and J. Köhl. 2001. Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma. Am. J. Respir. Crit. Care Med. 164: 1841-1843.
91. Drouin, S. M., D. B. Corry, T. J. Hollman, J. Kildsgaard, and R. A. Wetsel. 2002. Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy. J. Immunol. 169: 5926-5933.
92. Nakano, Y., S. Morita, A. Kawamoto, T. Suda, K. Chida, and H. Nakamura. 2003. Elevated complement C3a in plasma from patients with severe acute asthma. J. Allergy Clin. Immunol. 112: 525-530.
93. Kawamoto, S., A. Yalcindag, D. Laouini, S. Brodeur, P. Bryce, B. Lu, A. A. Humbles, H. Oettgen, C. Gerard, and R. S. Geha. 2004. The anaphylatoxin C3a downregulates the Th2 response to epicutaneously introduced antigen. J. Clin. Invest. 114: 399-407.
94. Mizutani, N., T. Nabe, and S. Yoshino. 2009. Complement C3a regulates late asthmatic response and airway hyperresponsiveness in mice. J. Immunol. 183: 4039-4046.
95. Klos, A., A. J. Tenner, K. O. Johswich, R. R. Ager, E. S. Reis, and J. Köhl. 2009. The role of the anaphylatoxins in health and disease. Mol. Immunol. 46: 2753-2766.
96. Mizutani, N., H. Goshima, T. Nabe, and S. Yoshino. 2012. Complement C3ainduced IL-17 plays a critical role in an IgE-mediated late-phase asthmatic response and airway hyperresponsiveness via neutrophilic inflammation in mice. J. Immunol. 188: 5694-5705.
97. Ferrer, M., K. Nakazawa, and A. P. Kaplan. 1999. Complement dependence of histamine release in chronic urticaria. J. Allergy Clin. Immunol. 104: 169-172.
98. Kikuchi, Y., and A. P. Kaplan. 2002. A role for C5a in augmenting IgGdependent histamine release from basophils in chronic urticaria. J. Allergy Clin. Immunol. 109: 114-118.
99. MacLaren, R., W. Cui, and K. Cianflone. 2008. Adipokines and the immune system: an adipocentric view. Adv. Exp. Med. Biol. 632: 1-21.
100. Liu, J., A. Divoux, J. Sun, J. Zhang, K. Clément, J. N. Glickman, G. K. Sukhova, P. J. Wolters, J. Du, C. Z. Gorgun, et al. 2009. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat. Med. 15: 940-945.
101. Brightling, C. E., P. Bradding, F. A. Symon, S. T. Holgate, A. J. Wardlaw, and I. D. Pavord. 2002. Mast-cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med. 346: 1699-1705.